CAS 91896-57-0

8-chloro-1-phenyl[1,2,4]triazolo[4,3-a]quinoxalin-4-amine

Description:

8-Chloro-1-phenyl[1,2,4]triazolo[4,3-a]quinoxalin-4-amine is a heterocyclic compound characterized by its complex structure, which includes a triazole and quinoxaline moiety. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity, making it of interest in medicinal chemistry. The presence of the chloro and phenyl groups can influence its reactivity and interaction with biological targets. It may also display specific pharmacological activities, which can be attributed to its unique structural features. The compound's molecular framework allows for potential applications in drug development, particularly in areas related to cancer research or as a scaffold for synthesizing other bioactive molecules. Additionally, its stability and reactivity can be influenced by the electronic effects of the substituents on the aromatic rings. Overall, 8-chloro-1-phenyl[1,2,4]triazolo[4,3-a]quinoxalin-4-amine represents a significant compound for further exploration in chemical and pharmaceutical research.

Formula: C₁₅H₁₀ClN₅

InChI: InChI=1/C15H10ClN5/c16-10-6-7-11-12(8-10)21-14(9-4-2-1-3-5-9)19-20-15(21)13(17)18-11/h1-8H,(H2,17,18)

SMILES: c1ccc(cc1)c1nnc2c(N)nc3ccc(cc3n12)Cl

Synonyms:

• [1,2,4]Triazolo[4,3-A]Quinoxalin-4-Amine, 8-Chloro-1-Phenyl-

CP-66713

CAS: 91896-57-0

Formula: C₁₅H₁₀ClN₅

Molecular weight: 295.73

Ref: 7W-GL6769

CP-66713

CAS: 91896-57-0

CP-66713 is a potentiator of adenosine receptors. It binds to the adenosine A1 receptor and blocks the presynaptic uptake of adenosine, thereby potentiating the effects of endogenous adenosine. CP-66713 has been shown to be effective in animal control experiments for depression, which may be due to its ability to increase levels of synaptic and hippocampal cAMP. CP-66713 also has anti-inflammatory properties, as it inhibits the release of polymorphonuclear leukocytes by inhibiting phosphodiesterase activity.

Formula: C₁₅H₁₀ClN₅

Purity: Min. 95%

Molecular weight: 295.72 g/mol

Ref: 3D-RDA89657

CP 66713

CAS: 91896-57-0

CP-66713 is an adenosine A2 receptor antagonist.

Formula: C₁₅H₁₀ClN₅

Color and Shape: Solid

Molecular weight: 295.73

Ref: TM-T31026